JGP Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
JGP Wealth Management's DGX Position: Q3 2026 in Review
JGP Wealth Management reduced its Quest Diagnostics (DGX) stake by 0.44% in Q3 2026, selling an estimated $68.7K and leaving 66,685 shares worth $15.5M. The position accounts for 1.37% of the portfolio, ranked #13.
JGP Wealth Management first reported a position in DGX in Q1 2020 and has held it in 27 quarters since. The position peaked at $15.6M in Q4 2022. 327 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- JGP Wealth Management held 66,685 shares of Quest Diagnostics worth $15.5M as of Q3 2026.
- JGP Wealth Management sold 297 Quest Diagnostics shares in Q3 2026, an estimated $68.7K.
- Quest Diagnostics made up 1.37% of JGP Wealth Management's portfolio in Q3 2026, its #13 holding.
- JGP Wealth Management first reported a position in Quest Diagnostics in Q1 2020 and has held it in 27 quarters since.
- JGP Wealth Management's Quest Diagnostics position peaked at $15.6M in Q4 2022.
- 327 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on JGP Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.